Labviva co-founders Nicholas Rioux, chief technology officer (L) and CEO Siamak Baharloo
Labviva nets $20M Series A to ease life science procurement process
Ordering and procuring supplies and materials for researchers and producers in the life sciences industry is an important step, but it can be a complex …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
